Biograph Vision

by Siemens Healthineers  · Based in Germany → — Bigger perspective. Better answers. Redefine PET/CT imaging with precision-driven performance.
Nuclear Medicine Oncology Radiology

Contact vendor
Regulatory Status Disclosed

Overview

Biograph Vision is a state-of-the-art Positron Emission Tomography/Computed Tomography (PET/CT) imaging system developed by Siemens Healthineers. It is designed to provide high image resolution and sensitivity for precise quantification, significantly impacting health outcomes across various clinical applications. The system features groundbreaking technological performance, including 3.2-mm lutetium oxyorthosilicate (LSO) crystals 100% covered by SiPMs, delivering high volumetric resolution and ultra-fast true time-of-flight (TOF) performance. This technology enables reduced scan times, lower injected doses for patients, and enhanced patient comfort. Biograph Vision aims to boost productivity, avoid unnecessary exposure, and increase throughput while providing consistent and accurate results.

The Biograph Vision system is part of the broader Biograph mCT family of PET/CTs, known for integrating high-resolution PET with premium diagnostic CT capabilities. It offers intelligent imaging capabilities and advanced features like OncoFreeze and CardioFreeze for motion correction, further improving image quality. Its design includes a generous 78-cm bore, which aids in patient positioning and comfort, especially for larger or claustrophobic patients. The system supports a wide variety of radioisotopes, making it suitable for theranostics and expanding research opportunities.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Optiso Ultra Dynamic Range (UDR) detector technology with 3.2-mm LSO crystals and SiPMs
  • High 48-mm3 volumetric resolution
  • 214-ps true time-of-flight (TOF) performance
  • Highest effective sensitivity at 100 cps/kBq
  • Reduced scan times (as low as 3 minutes for whole-body scans)
  • Lower injected radiopharmaceutical dose
  • 78-cm large bore for patient comfort and positioning
  • OncoFreeze and CardioFreeze for motion correction
  • Ultra Dynamic Range (UDR) for a wide spectrum of count rates
  • Support for a wide variety of radioisotopes for theranostics

Use Cases

  • Oncology (diagnosis, staging, treatment monitoring, radiation therapy planning)
  • Cardiology (myocardial blood flow assessment, cardiac imaging)
  • Neurology (assessment of neurological diseases, dementia diagnosis)
  • Theranostics (monitoring targeted radiopharmaceutical treatments)
  • Clinical research
  • Pediatric imaging

What Physicians Need to Know

Cardiac CT Analysis
The Biograph Vision's CT component can function as a high-end, standalone CT scanner for non-invasive assessment of coronary artery morphology. It offers high spatial and temporal resolution for cardiac CT imaging.
Myocardial Perfusion and Viability Assessment
The PET component is crucial for assessing myocardial perfusion, viability, and inflammation. It can identify left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction.
Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) Quantification
Biograph Vision supports the quantitative assessment of Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) using dynamic PET data, which are considered gold standards for prognosis assessment and Major Adverse Cardiac Events (MACE) prediction.
AI-Powered Motion Management (CardioFreeze)
The system features CardioFreeze technology, which incorporates AI-powered motion correction to address respiratory motion in the heart, leading to clearer PET/CT images.
Intelligent Imaging Platform (AIDAN)
Biograph Vision leverages AIDAN, an intelligent imaging platform for Biograph PET/CT scanners, which supports the demanding processing power of AI-based solutions for enhanced image quality and optimized workflows.
Coronary Artery Assessment
Beyond myocardial perfusion, the CT component can be used for non-invasive assessment of coronary artery morphology, contributing to the evaluation of coronary artery disease.
Heart Failure Risk Prediction (Indirect)
By providing precise quantification of myocardial function and perfusion, the system contributes valuable data for assessing heart failure risk. AI models are being developed to predict heart failure risk from CT scans, analyzing cardiac segments and other factors.
Physician Tip

Leverage Biograph Vision's advanced PET/CT capabilities, especially its AI-powered motion correction (CardioFreeze) and high-resolution imaging, to obtain precise myocardial perfusion and viability assessments. Utilize the quantitative MBF and MFR data for comprehensive prognostic evaluation in patients with coronary artery disease and left ventricular dysfunction. The integrated AI platform can streamline workflows and enhance the accuracy of cardiac CT analysis, aiding in early detection and personalized treatment strategies.

The Biograph Vision system integrates AI-powered algorithms through its AIDAN intelligent imaging platform, enabling advanced image processing and workflow enhancements directly on the scanner and through reading solutions like syngo.via. This platform supports features like FlowMotion AI and OncoFreeze AI, optimizing scan protocols and image quality.

Details

Category Cardiology AI, Oncology AI, Radiology & Imaging AI
Pricing Contact vendor — N/A
DeploymentOn-premise (physical medical device)
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Yes AI-estimated

The Biograph Vision PET/CT imaging system received FDA clearance (510(k) Premarket Notification K193248) on February 14, 2020. Earlier versions or components of the Biograph Vision also received FDA clearance, with the Biograph Vision PET/CT system gaining clearance in June 2018.

Integrations
EHR Not specified
Specialties Nuclear Medicine, Oncology, Radiology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Biograph Vision

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Siemens Healthineers
Siemens Healthineers Debuts Biograph Vision.X PET/CT Scanner
Siemens Healthineers introduced the Biograph Vision.X PET/CT scanner at SNMMI 2023, featuring an industry-best time of flight of 178 ps for improved lesion detection and anatomical detail. The system also incorporates AI-powered applications for increased operational efficiency and an accelerated patient workflow.
2023-06
Applied Radiation Oncology
Siemens Launches New PET/CT Scanner at SNMMI 2023
Siemens Healthineers debuted the Biograph Vision.X PET/CT scanner at the 2023 SNMMI Annual Meeting, highlighting its 178 picosecond Time of Flight (TOF) and Optiso Ultra Dynamic Range (UDR) detector technology for higher spatial resolution. The system aims to improve patient throughput, reduce radiation exposure, and lower radiotracer costs.
2023-06
Siemens Healthineers
Siemens Healthineers Announces FDA Clearance of Biograph Vision.X PET/CT Scanner
Siemens Healthineers received FDA clearance for its Biograph Vision.X PET/CT scanner in November 2023. This system features an industry-leading 178 picosecond Time of Flight (TOF) and Optiso Ultra Dynamic Range (UDR) detector technology, designed to enhance image resolution and improve patient outcomes.
2023-11
Journal of Nuclear Medicine
Performance Evaluation of the Biograph Vision.X: A High Time-of-Flight Coincidence Time Resolution PET/CT Scanner | Journal of Nuclear Medicine
This study evaluated the performance of the Biograph Vision.X PET/CT system, demonstrating its superior time-of-flight performance and improved image contrast compared to its predecessor, the Biograph Vision 600. The system achieved a TOF resolution of 178.7 to 182 ps.
2025-06
Siemens Healthineers
Siemens Healthineers Announces FDA Clearance of Biograph Vision Quadra Extended Axial FoV PET/CT Scanner
Siemens Healthineers announced FDA clearance for the Biograph Vision Quadra, a PET/CT scanner with an extended 106 cm axial field of view. This system is designed for both clinical use and translational research, enabling simultaneous whole-body imaging and expanding precision medicine.
2021-03
Siemens Healthineers
FDA Clears AIDAN Artificial Intelligence for Siemens Healthineers Biograph PET/CT Portfolio
Siemens Healthineers received FDA clearance for its AIDAN artificial intelligence technologies across the Biograph PET/CT family, including Biograph Vision. AIDAN aims to enhance operational efficiency and workflow through features like FlowMotion AI and OncoFreeze AI.
2020-04
PubMed (Journal of Nuclear Medicine)
Image Quality and Activity Optimization in Oncologic 18F-FDG PET Using the Digital Biograph Vision PET/CT System - PubMed
This study, published in the Journal of Nuclear Medicine, investigated the Biograph Vision PET/CT system's performance in oncologic 18F-FDG PET imaging, suggesting that its improved performance could allow for reduced activity administration or scan duration while maintaining image quality.
2020-05
Journal of Nuclear Medicine
Systematic Quantitative and Image Quality Performance Comparison Between PET Biograph Systems: A Phantom Measurement and Monte Carlo Study
This study compared the image quality and performance of Biograph Vision, Biograph Vision Quadra, and Biograph One PET systems, highlighting differences in their geometries and time resolutions. The research utilized a clinically realistic phantom to assess quantification accuracy and convergence.
2026-05

Videos

Product demos, reviews, and walkthroughs for Biograph Vision.

View all on YouTube

Frequently Asked Questions

The Biograph Vision integrates AI through platforms like AIDAN and features such as FlowMotion AI and OncoFreeze AI, which optimize image acquisition, reduce scan times, and correct for patient motion. This leads to improved image quality, more precise lesion detection, and streamlined diagnostic workflows.
Biograph Vision and its integrated AI technologies, such as AIDAN, have received necessary regulatory clearances, including FDA clearance in the U.S. Siemens Healthineers also implements robust cybersecurity and data anonymization protocols to ensure patient data privacy and compliance with regulations like HIPAA.
Biograph Vision is noted for its high sensitivity, resolution, and fast Time-of-Flight (TOF) performance, which are foundational for its AI applications in image reconstruction and quantitative analysis. While competitors like GE Discovery MI and Philips Vereos also offer advanced AI, Biograph Vision's specific algorithms leverage its unique hardware for enhanced performance.
The pricing for Biograph Vision's AI features is typically integrated into the overall system acquisition cost. There may be additional costs for specific software packages, upgrades, and recurring service contracts that cover ongoing software updates and access to future AI enhancements.
AI algorithms can have limitations such as potential biases from their training datasets, a lack of transparency (the 'black box' phenomenon), and may perform less optimally in rare or unusual pathologies. Physicians must exercise clinical judgment, critically evaluate AI-generated findings, and integrate them with comprehensive patient information, especially in ambiguous cases.
The physician retains ultimate responsibility for patient diagnosis and treatment, with AI serving as a sophisticated decision support tool. The system is designed to allow physicians to critically review, validate, and override AI recommendations based on their clinical expertise and the overall patient context.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from Siemens Healthineers

AI-Rad Companion (Pulmonary)
Siemens Healthineers
Radiology & Imaging AI
AI-Rad Companion (Pulmonary) by Siemens Healthineers is an AI-powered image processing software for quantitative and qualitative analysis of lung CT images, aiding physicians in evaluating and assessing pulmonary diseases.
AI-Rad Companion Organs RT
Siemens Healthineers
Oncology AI
AI-Rad Companion Organs RT by Siemens Healthineers is an AI-powered software that automates the contouring of organs at risk (OARs) on CT and MR images for radiation therapy planning, aiming to improve efficiency and consistency.
Biograph Horizon
Siemens Healthineers
Neurology AI
The Siemens Healthineers Biograph Horizon is an advanced PET/CT medical imaging system that combines PET and CT scans for comprehensive diagnostic information in oncology, neurology, and cardiology. It is not an AI tool for a physician directory.
LUMINOS Q.namix R
Siemens Healthineers
Radiology & Imaging AI
Siemens Healthineers' LUMINOS Q.namix R is a multifunctional remote imaging system for fluoroscopy and radiography, featuring AI-supported workflow guidance for streamlined operations and low-dose imaging. It is FDA cleared for a diverse range of medical examinations.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.